What is the production process of a generic pharma manufacturer?
Before generic pharmaceutical companies can begin formulating and manufacturing the bioequivalent of brand-name drugs, a few things must first take place. When a pharmaceutical company develops a new drug, a protective patent allows this company to sell this drug for a specific amount of time. If this company is based in the United States, these patents last for 17 years. Once this patent expires, a generic drug manufacturer can file an Abbreviated New Drug Application (ANDA) with the FDA to begin the process of developing and formulating the bioequivalent of a brand-name pharmaceutical. Upon meeting the necessary formulation requirements and facility standards, these generic pharmaceutical companies can start manufacturing.
The production process for generic pharmaceuticals depends on the specific drug being manufactured. When UPM partners with a client as a generic pharmaceutical CDMO, we strive to mirror their organization to ensure a clear, mutual understanding of all development, manufacturing, quality and regulatory considerations. As an experienced generic pharma manufacturer, we possess specialized handling capabilities that allow us to manufacture semi-solid, solid dose, high-potent generic pharmaceuticals.
Our Experience as a Generic Pharmaceutical CDMO
Our annual production capabilities make us an ideal generic pharma manufacturing partner. We have produced:
- 3.5 billion tablets
- 680 million capsules
- 1,300 metric tons of semi-solids
Our large manufacturing facility and warehouse allow us to handle the commercial manufacturing demands of your project.
Read more about trends in generic drug manufacturing
CONTACT US
Consider Generic Drug Manufacturing with UPM Pharmaceuticals
If you have a project that requires a trusted, award-winning generic drug manufacturer, UPM Pharmaceuticals can help. Contact us online today or call +1 423-989-8000. If you'd like to learn more about our experience and capabilities, take a look at the related article and pages below.
Contact Us
